検索結果 - M. Santer
- 検索結果 1 - 6 結果 / 6
-
1
-
2
-
3
How has the COVID‐19 pandemic affected eczema self‐management and help seeking? A qualitative interview study with young people and parents/carers of children with eczema 著者: M. Steele, L. Howells, M. Santer, K. Sivyer, S. Lawton, A. Roberts, E. Teasdale, I. Muller, K. Greenwell
出版年 Skin Health and Disease (2021-12-01)全文の入手
論文 -
4
Do patient characteristics matter when calculating sample size for eczema clinical trials? 著者: L. Howells, S. Gran, J. R. Chalmers, B. Stuart, M. Santer, L. Bradshaw, D. M. Gaunt, M. J. Ridd, L. A. A. Gerbens, P. I. Spuls, C. Huang, N. A. Francis, K. S. Thomas
出版年 Skin Health and Disease (2021-09-01)全文の入手
論文 -
5
A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humans. 著者: John Lok Man Law, Chao Chen, Jason Wong, Darren Hockman, Deanna M Santer, Sharon E Frey, Robert B Belshe, Takaji Wakita, Jens Bukh, Christopher T Jones, Charles M Rice, Sergio Abrignani, D Lorne Tyrrell, Michael Houghton
出版年 PLoS ONE (2013-01-01)全文の入手
論文 -
6
No evidence for XMRV nucleic acids, infectious virus or anti-XMRV antibodies in Canadian patients with chronic fatigue syndrome. 著者: Imke Steffen, D Lorne Tyrrell, Eleanor Stein, Leilani Montalvo, Tzong-Hae Lee, Yanchen Zhou, Kai Lu, William M Switzer, Shaohua Tang, Hongwei Jia, Darren Hockman, Deanna M Santer, Michael Logan, Amir Landi, John Law, Michael Houghton, Graham Simmons
出版年 PLoS ONE (2011-01-01)全文の入手
論文
